Isabelle Wegmann Hachette[email protected]Ultrasound3D/4D ultrasound matures as it shows clinical valueInitially a technology used only by early adopters, 3D/4D ultrasound has indeed come of age, buoyed by mounting evidence of its diagnostic utility in a variety of clinical applications. Today, 3D/4D ultrasound is increasingly being used by healthcare institutions around the world.October 18, 2016Ultrasound3D/4D ultrasound imaging: Coming of ageAlthough high-performance 3D/4D technology has been available in ultrasound for years, it hasn't routinely been used in all clinical practices. That may change in 2013, however, thanks to a number of key trends that are expected to drive widespread adoption.January 3, 2013Page 1 of 1Top StoriesMRICNN techniques outperform conventional DL for Alzheimer's diagnosisConvolutional neural network (CNN) techniques outperform conventional deep learning (DL) methods in diagnosing Alzheimer's.Womens ImagingAbout half of women undecided on AI's use in breast imagingISMRMISMRM president outlines key highlights of the upcoming annual meeting in HonoluluMolecular ImagingSPECT/CT MPI may guide medical therapy in CAD patientsMRIAI model uses MRI data to predict brain cancer patient survival
![Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2025/05/2025-05-06-rsna-ultrafast-dce-mri-breast.Gzvq76udFr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
